GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Market Cap

Invictus MD Strategies (Invictus MD Strategies) Market Cap : $0.00 Mil (As of May. 05, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Invictus MD Strategies's share price for the quarter that ended in Oct. 2019 was $0.11. Invictus MD Strategies's Shares Outstanding (EOP) for the quarter that ended in Oct. 2019 was 124.58 Mil. Therefore, Invictus MD Strategies's market cap for the quarter that ended in Oct. 2019 was $13.70 Mil.

Invictus MD Strategies's quarterly market cap declined from Apr. 2019 ($61.67 Mil) to Jul. 2019 ($32.39 Mil) and declined from Jul. 2019 ($32.39 Mil) to Oct. 2019 ($13.70 Mil).

Invictus MD Strategies's annual market cap increased from Jan. 2017 ($30.90 Mil) to Jan. 2018 ($151.83 Mil) but then declined from Jan. 2018 ($151.83 Mil) to Jan. 2019 ($103.25 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Invictus MD Strategies's Enterprise Value for Today is $0.00 Mil.


Invictus MD Strategies Market Cap Historical Data

The historical data trend for Invictus MD Strategies's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Market Cap Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Market Cap
- 1.45 30.90 151.83 103.25

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.81 103.25 61.67 32.39 13.70

Competitive Comparison of Invictus MD Strategies's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's Market Cap distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's Market Cap falls into.



Invictus MD Strategies Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Invictus MD Strategies's Market Cap for the fiscal year that ended in Jan. 2019 is calculated as

Market Cap (A: Jan. 2019 )=Share Price (A: Jan. 2019 )*Shares Outstanding (EOP) (A: Jan. 2019 )
=$0.86*120.055
=$103.25

Invictus MD Strategies's Market Cap for the quarter that ended in Oct. 2019 is calculated as

Market Cap (Q: Oct. 2019 )=Share Price (Q: Oct. 2019 )*Shares Outstanding (EOP) (Q: Oct. 2019 )
=$0.11*124.583
=$13.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Invictus MD Strategies  (OTCPK:IVITF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Invictus MD Strategies Market Cap Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines

From GuruFocus

UPDATE ON ACREAGE PHARMS LTD.

By Marketwired Marketwired 06-12-2019

INVICTUS CLOSES SALE OF 0989561 BC LTD. DBA CANANDIA BIOCEUTICALS

By Marketwired Marketwired 09-24-2019

INVICTUS ANNOUNCES $5,700,000 CONVERTIBLE DEBENTURE FINANCING

By Marketwired Marketwired 12-16-2019

INVICTUS ANNOUNCES RESIGNATIONS

By Marketwired Marketwired 12-06-2019

INVICTUS ANNOUNCES CHANGE TO BOARD

By Marketwired Marketwired 12-14-2019

ACREAGE PHARMS LTD. GRANTED OIL SALES LICENSE

By Marketwired Marketwired 08-14-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. RECEIVES AMENDED LICENSE

By Marketwired Marketwired 09-11-2019

INVICTUS ANNOUNCES AB LABORATORIES INC. UPDATE

By Marketwired Marketwired 06-26-2019